Hepatitis C (HCV) Rapid Antibody Test

Hepatitis C Virus (HCV) is a small, enveloped, positive-sense, single-stranded RNA virus. It is the major cause of parenterally transmitted non-A, non-B hepatitis, and is primarily transmitted through blood-to-blood contact. The most common modes of transmission include sharing contaminated needles, receiving blood products that have not been screened for HCV, or through unprotected sexual contact. If left untreated, HCV can develop into a chronic infection, leading to liver inflammation and damage. Over time, chronic HCV infection can cause serious complications such as cirrhosis, liver failure, and even liver cancer. Early diagnosis and treatment of HCV infection are essential to prevent these long-term health issues and to reduce the risk of transmission to others.

The Hepatitis C (HCV) Rapid Antibody Test is an immunochromatographic method designed to quickly detect antibodies against the Hepatitis C virus (anti-HCV) in human serum, plasma, or whole blood samples. This test is simple to use and provides reliable results in just 10-15 minutes. By detecting the presence of anti-HCV antibodies, the test helps healthcare providers identify individuals who have been exposed to HCV and are at risk of developing chronic infection. If the test result is positive, immediate action can be taken, and further diagnostic testing or treatment can begin without delay. Early intervention can prevent further liver damage and improve the overall prognosis for those infected with HCV.

The HCV Rapid Antibody Test is particularly valuable in clinical settings such as hospitals, clinics, and blood banks. Its quick results enable healthcare professionals to make fast decisions regarding treatment and care. This test is also an essential tool for routine screening programs, helping to identify individuals at risk of HCV infection and manage potential outbreaks. Regular testing is key to controlling the spread of Hepatitis C and ensuring that those affected receive timely care. By enabling early detection, this test helps in reducing the public health burden of HCV-related liver diseases.

Developed by Omega Biotech, the HCV Rapid Antibody Test offers a reliable and user-friendly solution for Hepatitis C screening. It is an invaluable tool for both healthcare providers and individuals, allowing for faster diagnosis, quicker treatment initiation, and better health outcomes. The test plays a crucial role not only in safeguarding individual health but also in improving public health by preventing the transmission of HCV. Early detection through this rapid test helps to mitigate the long-term complications associated with Hepatitis C, offering a better chance of managing the infection and improving quality of life.

Sample types: Whole Blood/Serum/Plasma

Sensitivity: 98.7 %

Specificity: 99%

Q-Check Hepatitis C Virus (HCV) Rapid Antigen Test                                                                                                   25T/Box                              QCH-0005-25

                                                        Single Test/Box                   QCH-0005-1